Theme
Obesity
The anti-obesity drug market and its knock-on effects across health.
The anti-obesity drug market centers on incretin therapies that produce significant, sustained weight loss. Its growth carries knock-on effects across cardiovascular, metabolic, and other areas of health.
Companies · 5
Amgen Inc.AMGN
Market cap$182B
Conviction5 / 5
GLP-1Obesity
Read profileEli Lilly and CompanyLLY
Market cap$985B
Conviction5 / 5
GLP-1Obesity
Read profileNovo Nordisk A/SNVO
Market cap$202B
Conviction4 / 5
GLP-1Obesity
Read profileStructure Therapeutics Inc.GPCR
Market cap$2.8B
Conviction3 / 5
ObesityGLP-1
Read profileViking Therapeutics, Inc.VKTX
Market cap$3.8B
Conviction3 / 5
ObesityMetabolic disease
Read profile